课题基金 / 基金详情

A DOUBLE-BLIND, RANDOMIZED, CONTROLLED PHASE III STUDY TO ASSESS THE PROPHYLAC

A DOUBLE-BLIND, RANDOMIZED, CONTROLLED PHASE III STUDY TO ASSESS THE PROPHYLAC
评估预防效果的双盲、随机、对照 III 期研究
批准号:
7952038
负责人:
Gregory James Mertz
金额:
$7.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-11-30

项目摘要

项目成果

Gregory James Mertz的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The main purpose of this research is to determine whether the study vaccine protects women who are HSV-1 [herpes simplex virus] and HSV-2 negative against the development of genital herpes
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A DOUBLE-BLIND, RANDOMIZED, CONTROLLED PHASE III STUDY TO ASSESS THE PROPHYLAC
  • 批准号:
    8166588
  • 项目类别:
  • 资助金额:
    $0.48万
  • 财政年份:
    2009
  • 负责人:
    Gregory James Mertz
  • 依托单位:
CLINICAL TRIAL: A DOUBLE-BLIND, RANDOMIZED, CONTROLLED PHASE III STUDY TO ASSESS
  • 批准号:
    7716566
  • 项目类别:
  • 资助金额:
    $17.4万
  • 财政年份:
    2008
  • 负责人:
    Gregory James Mertz
  • 依托单位:
A DOUBLE-BLIND, RANDOMIZED, CONTROLLED PHASE III STUDY TO ASSESS THE PROPHYLAC
  • 批准号:
    7606870
  • 项目类别:
  • 资助金额:
    $25.1万
  • 财政年份:
    2006
  • 负责人:
    Gregory James Mertz
  • 依托单位:
Administrative/Clinical Core
  • 批准号:
    6970473
  • 项目类别:
  • 资助金额:
    $27.8万
  • 财政年份:
    2005
  • 负责人:
    Gregory James Mertz
  • 依托单位: